NCT01608230

Brief Summary

This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

May 25, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 31, 2012

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

November 18, 2014

Status Verified

November 1, 2014

Enrollment Period

4 years

First QC Date

May 25, 2012

Last Update Submit

November 17, 2014

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

  • Determine biomarkers of clinical utility and copy number variants through genetic analysis.

    four years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cancer

You may qualify if:

  • Diagnosis of a solid tumor or blood borne cancer
  • years or older
  • Eligible to have blood drawn

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Scripps Translational Science Institute

La Jolla, California, 92037, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

May 25, 2012

First Posted

May 31, 2012

Study Start

April 1, 2010

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

November 18, 2014

Record last verified: 2014-11

Locations

US(1)